Clinical trials
2 active studies led by Emblok, Inc., of 3 in all
Source: ClinicalTrials.gov, Studies with Emblok, Inc. (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
- 0Reports naming them
- 1Markets in public records
- 0Regions & countries
- 2Active trials they lead[1]
[1] ClinicalTrials.gov, Studies led by Emblok, Inc. or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
Free public data on Emblok, Inc.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
See them on ClinicalTrials.gov (opens in a new tab)
Trials over time
Studies Emblok, Inc. leads, by the year they started and their phase
- Phase 1
- Phase 2
- Phase 3
- Phase 4
- No phase (devices, observational)
Source: ClinicalTrials.gov, Studies with Emblok, Inc. or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets where public records show them
Markets we cover where free public records show Emblok, Inc.: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
Topics
The topics of the markets Emblok, Inc. is in.
From our blog
Stories on the topics Emblok, Inc. works in.
Omega-3: Heart, Brain and the Evidence Debate
Omega-3 supplements are hugely popular. Big trials give mixed answers on whether they protect the heart.
Read
Angiography: Seeing Inside the Blood Vessels
Cardiovascular disease is the world's leading cause of death, and stroke caused 11.9 million new cases in…
Read
Angioplasty Balloons and Heart Care in India
In 2017 India capped coronary stent prices, cutting drug-eluting stent prices by about 85%. Heart disease is…
Read